Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Even within a clinical trial, the "usual care" arm—referring patients to the national NCI quit line—saw only 5% of patients complete a single session. This shockingly low engagement proves that passive referrals are ineffective, essentially leaving patients to quit on their own. It highlights the urgent need for proactive, integrated treatment models.

Related Insights

A key for scaling cessation programs is likely "hiding in plain sight" within existing Electronic Health Record (EHR) systems. Modern EHRs have built-in capabilities for assessing smoking status and creating automated referrals or treatment orders. Activating these latent features can systematically integrate tobacco treatment into routine clinical care without significant new investment.

The trial's success stems from its pragmatic design, which broadly included any cancer patient who smoked recently, regardless of their motivation to quit. This contrasts with traditional trials that select highly motivated volunteers, making these findings more applicable to typical, diverse patient populations in real-world cancer care.

The successful intervention was perceived as "intense," but its key was being "sustained." Later counseling sessions were brief (15-20 minute) check-ins. This demonstrates that consistent, long-term psychosocial support and relapse prevention, rather than the intensity of any single session, drives positive outcomes for patients making difficult health changes.

The systemic process for referring SCLC patients from community clinics to academic centers for trials is too slow. The most effective solution is not a systems overhaul but for community physicians to build direct communication channels (text, email) with academic specialists to "make a spot" and bypass formal referral backlogs.

The industry's standard practice of selecting sites based on pre-existing relationships and convenience—the "easy button"—is a primary driver of failure. This leads to 80% of activated sites missing enrollment targets and 30% enrolling zero patients, a massive, systemic inefficiency that data-driven approaches can solve.

Simple text reminders for medication adherence are common. The real opportunity is using two-way, AI-powered texting to create conversations that uncover the specific reasons (out of over 250 identified) why a patient might stop taking their medication, allowing for timely and personalized interventions.

Instead of immediately agreeing, an effective clinician asks why the person wants to change. This forces the individual to articulate and build their own internal motivation, which is far more powerful and durable than external pressure or simple agreement from a therapist.

Healthcare systems invest heavily in diagnosis but then abandon patients once a prescription is handed over. This "disconnection point" leads to medication non-adherence and confusion, as the patient's actual healing journey is just beginning and requires ongoing support.

Healthcare providers invest heavily in patient portals and custom apps but struggle with adoption. The core problem isn't the app's design but the high friction of getting users to download and engage. Texting (SMS) bypasses this by leveraging the one universal communication app patients already have installed with notifications enabled.

The asynchronous nature of texting is a key advantage for patient support programs. Unlike a phone call that demands an immediate response and can lead to a frustrating busy signal, texting allows patients to engage on their own time. This low-pressure interaction model significantly reduces barriers and encourages more people to reach out.